01.09.2006 | Phase II Studies
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282
Erschienen in: Investigational New Drugs | Ausgabe 5/2006
Einloggen, um Zugang zu erhalten